Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

As the genetic testing company 23andMe prepares for a major sale, Congress is raising concerns about the privacy of the data collected from millions of customers.

Lawmakers are demanding answers from 23andMe regarding how they will protect the sensitive genetic information of their users.

There are worries that the sale of 23andMe could lead to the exploitation of personal data for profit.

Several members of Congress have expressed the need for stronger regulations to safeguard genetic data and prevent its misuse.

The issue of data privacy has become increasingly important as more companies collect and store vast amounts of personal information.

Consumers are becoming more aware of the risks associated with sharing their data and are calling for greater transparency and accountability from companies like 23andMe.

Companies that handle sensitive information, such as genetic data, must be held to the highest standards of data protection.

Congress is expected to hold hearings on data privacy in the coming weeks to address these concerns and ensure the safety of consumers’ personal information.

It remains to be seen what measures 23andMe will put in place to protect the privacy of its customers as it goes through the sale process.

Ultimately, the outcome of this sale could have far-reaching implications for data privacy and consumer trust in the digital age.